Laura A. Johnson

18.7k total citations · 3 hit papers
127 papers, 9.2k citations indexed

About

Laura A. Johnson is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Laura A. Johnson has authored 127 papers receiving a total of 9.2k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Oncology, 36 papers in Immunology and 32 papers in Genetics. Recurrent topics in Laura A. Johnson's work include CAR-T cell therapy research (30 papers), Immunotherapy and Immune Responses (23 papers) and Inflammatory Bowel Disease (18 papers). Laura A. Johnson is often cited by papers focused on CAR-T cell therapy research (30 papers), Immunotherapy and Immune Responses (23 papers) and Inflammatory Bowel Disease (18 papers). Laura A. Johnson collaborates with scholars based in United States, China and United Kingdom. Laura A. Johnson's co-authors include Steven A. Rosenberg, Andrew P. Feinberg, Mark E. Dudley, Bianca Heemskerk, Mojgan Ahmadzadeh, John R. Wunderlich, Donald E. White, Peter Higgins, Carl H. June and Maxwell P. Lee and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Laura A. Johnson

120 papers receiving 9.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor antigen–specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired

2009 1.4k citations Laura A. Johnson, Bianca Heemskerk et al. profile →
Relaxation of imprinted genes in human cancer

1993 663 citations Laura A. Johnson et al. profile →
Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity

2013 515 citations Liang‐Chuan S. Wang, Albert Lo et al. Cancer Immunology Research profile →

Peers

Countries citing papers authored by Laura A. Johnson

Since Specialization

Citations

This map shows the geographic impact of Laura A. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura A. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura A. Johnson more than expected).

Fields of papers citing papers by Laura A. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura A. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura A. Johnson. The network helps show where Laura A. Johnson may publish in the future.

Co-authorship network of co-authors of Laura A. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Laura A. Johnson. A scholar is included among the top collaborators of Laura A. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura A. Johnson. Laura A. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sa1814 REAL-WORLD USE OF PATIENT REPORTED OUTCOME MEASURES AT A LARGE TERTIARY INFLAMMATORY BOWEL DISEASE CENTER 2024 ·Gastroenterology ·(unknown), Laura A. Johnson, Shirley Cohen‐Mekelburg, Peter Higgins	1
2	Su1775 SOCIALLY VULNERABLE PATIENTS WITH INFLAMMATORY BOWEL DISEASE ARE AT INCREASED RISK FOR VACCINE PREVENTABLE ILLNESS 2023 ·Gastroenterology ·(unknown), (unknown), Kira L. Newman, (unknown), Laura A. Johnson, Shirley Cohen‐Mekelburg, Renuka Tipirneni, Peter Higgins	1
3	CSL324, a granulocyte colony-stimulating factor receptor antagonist, blocks neutrophil migration markers that are upregulated in hidradenitis suppurativa 2023 ·British Journal of Dermatology ·Cristina Gamell, Aleksandra Bankovacki, Karen Scalzo‐Inguanti, Bradley J. Sedgmen, Monther Alhamdoosh, (unknown), (unknown), (unknown), Laura A. Johnson, (unknown), (unknown), (unknown), (unknown), (unknown), George Varigos, Milica Ng, Nick Wilson, (unknown), Johannes S. Kern, Lisa Lindqvist	11
4	Functional analysis of autocrine and paracrine signalling at the uterine–conceptus interface in pigs 2020 ·Bioscientifica Proceedings ·Laurie A. Jaeger, Laura A. Johnson, Hakhyun Ka, (unknown), Robert C. Burghardt, Thomas E. Spencer, F. W. Bazer	3
5	Rapid, accurate, and precise concentration measurements of a methanol–water mixture using Raman spectroscopy 2018 ·OSA Continuum ·Daniel D. Hickstein, (unknown), (unknown), (unknown), Laura A. Johnson	6
6	Recognition and Killing of Autologous, Primary Glioblastoma Tumor Cells by Human Cytomegalovirus pp65-Specific Cytotoxic T Cells 2014 ·Clinical Cancer Research ·Smita K. Nair, Gabriel De Leon, David Boczkowski, Robert J. Schmittling, Weihua Xie, Janet Staats, Rebecca Liu, Laura A. Johnson, Kent J. Weinhold, Gary E. Archer, John H. Sampson, Duane A. Mitchell	74
7	P106 Ultrasound shear wave elastography detects bowel wall fibrosis in ex vivo human Crohn's disease specimens 2014 ·Journal of Crohn s and Colitis ·Peter Higgins, (unknown), Ryan W. Stidham, Laura A. Johnson, (unknown)	1
8	EGFRvIII mCAR-Modified T-Cell Therapy Cures Mice with Established Intracerebral Glioma and Generates Host Immunity against Tumor-Antigen Loss 2013 ·Clinical Cancer Research ·John H. Sampson, Bryan D. Choi, Luis Sánchez-Pérez, Carter M. Suryadevara, David J. Snyder, Catherine Flores, Robert J. Schmittling, Smita K. Nair, Elizabeth A. Reap, Pamela K. Norberg, James E. Herndon, Chien-Tsun Kuan, Richard A. Morgan, Steven A. Rosenberg, Laura A. Johnson	241
9	T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapy 2013 ·Proceedings of the National Academy of Sciences ·Zhong Shi, Karolina Malecek, Laura A. Johnson, Zhiya Yu, (unknown), Farbod Darvishian, (unknown), Kevin Huang, Josh Boyer, Emily Corse, Yongzhao Shao, Steven A. Rosenberg, Nicholas P. Restifo, Iman Osman, Michelle Krogsgaard	178
10	T cell receptor affinity and avidity defines antitumor response and autoimmunity in T cell immunotherapy 2013 ·Journal for ImmunoTherapy of Cancer ·Michelle Krogsgaard, Zhong Shi, Karolina Malecek, Laura A. Johnson, Zhiya Yu, Eleazar Vega‐Saenz de Miera, Farbod Darvishian, (unknown), Kevin Huang, (unknown), Emily Corse, Yongzhao Shao, Steven A. Rosenberg, Nicholas P. Restifo, Iman Osman	13
11	Targeting Fibroblast Activation Protein in Tumor Stroma with Chimeric Antigen Receptor T Cells Can Inhibit Tumor Growth and Augment Host Immunity without Severe Toxicity breakdown → 2013 ·Cancer Immunology Research ·Liang‐Chuan S. Wang, Albert Lo, John Scholler, Jing Sun, R. Sonali Majumdar, Veena Kapoor, Michael Antzis, Cody E. Cotner, Laura A. Johnson, Amy C. Durham, Charalambos Solomides, Carl H. June, Ellen Puré, Steven Μ. Albelda	515
12	Recognition of Glioma Stem Cells by Genetically Modified T Cells Targeting EGFRvIII and Development of Adoptive Cell Therapy for Glioma 2012 ·Human Gene Therapy ·Richard A. Morgan, Laura A. Johnson, Jeremy L. Davis, Zhili Zheng, Kevin Woolard, Elizabeth A. Reap, Steven A. Feldman, Nachimuthu Chinnasamy, Chien-Tsun Kuan, Hua Song, Wei Zhang, Howard A. Fine, Steven A. Rosenberg	246
13	Spironolactone and Colitis: Increased Mortality in Rodents and in Humans 2011 ·Inflammatory Bowel Diseases ·Laura A. Johnson, Shail M. Govani, Joel C. Joyce, Akbar K. Waljee, Brenda W. Gillespie, Peter Higgins	12
14	Intestinal fibrosis is reduced by early elimination of inflammation in a mouse model of IBD: Impact of a “Top-Down” approach to intestinal fibrosis in mice 2011 ·Inflammatory Bowel Diseases ·Laura A. Johnson, Amy Luke, Kay Sauder, David S. Moons, Jeffrey C. Horowitz, Peter Higgins	94
15	An Oncogenic Role for ETV1 in Melanoma 2010 ·Cancer Research ·Judit Jané‐Valbuena, Hans R. Widlund, Sven Perner, Laura A. Johnson, (unknown), William M. Lin, Alissa C. Baker, Rosalynn M. Nazarian, Krishna G. Vijayendran, William R. Sellers, William C. Hahn, Lyn M. Duncan, Mark A. Rubin, David E. Fisher, Levi A. Garraway	81
16	Quantitative analysis of pulmonary artery and pulmonary collaterals in preoperative patients with pulmonary artery atresia using dual-source computed tomography 2010 ·European Journal of Radiology ·Lei Yin, Bin Lü, Lei Han, Runze Wu, Laura A. Johnson, (unknown), Shiliang Jiang, (unknown)	13
17	Prior Helicobacter pylori infection ameliorates Salmonella typhimurium-induced colitis 2010 ·Inflammatory Bowel Diseases ·Peter Higgins, Laura A. Johnson, Jay Luther, Min Zhang, Kay Sauder, Luz P. Blanco, John Y. Kao	64
18	Prevalence of TMPRSS2-ERG Fusion Prostate Cancer among Men Undergoing Prostate Biopsy in the United States 2009 ·Clinical Cancer Research ·Juan Miguel Mosquera, Rohit Mehra, Meredith M. Regan, Sven Perner, Elizabeth M. Genega, (unknown), Rajal B. Shah, Sandra M. Gaston, Scott A. Tomlins, John T. Wei, Michael Kearney, Laura A. Johnson, (unknown), Arul M. Chinnaiyan, Mark A. Rubin, Martin G. Sanda	164
19	Single and Dual Amino Acid Substitutions in TCR CDRs Can Enhance Antigen-Specific T Cell Functions 2008 ·The Journal of Immunology ·Paul F. Robbins, Yong F. Li, Mona El‐Gamil, Yangbing Zhao, Jennifer A. Wargo, Zhili Zheng, Hui Xu, Richard A. Morgan, Steven A. Feldman, Laura A. Johnson, Alan Bennett, Steven M. Dunn, Tara Mahon, Bent K. Jakobsen, Steven A. Rosenberg	252
20	Gene Transfer of Tumor-Reactive TCR Confers Both High Avidity and Tumor Reactivity to Nonreactive Peripheral Blood Mononuclear Cells and Tumor-Infiltrating Lymphocytes 2006 ·The Journal of Immunology ·Laura A. Johnson, Bianca Heemskerk, Daniel J. Powell, Cyrille J. Cohen, Richard A. Morgan, Mark E. Dudley, Paul F. Robbins, Steven A. Rosenberg	240

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact